Synonyms: | |
Status: | Approved (2014) |
Entry Type: | Small molecule |
Molecule Category: | Parent |
UNII: | 2302768XJ8 |
InChI Key | PIDFDZJZLOTZTM-KHVQSSSXSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C50H67N7O8 |
Molecular Weight | 894.13 |
AlogP | 7.69 |
Hydrogen Bond Acceptor | 9.0 |
Hydrogen Bond Donor | 4.0 |
Number of Rotational Bond | 13.0 |
Polar Surface Area | 178.72 |
Molecular species | NEUTRAL |
Aromatic Rings | 3.0 |
Heavy Atoms | 65.0 |
Action | Mechanism of Action | Reference |
---|---|---|
INHIBITOR | Nonstructural protein 5A inhibitor | FDA |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Enzyme
Protease
Serine protease
Serine protease PA clan
Serine protease S29 family
Serine protease S29 regulatory subfamily
|
- | - | - | - | 100 | |
Enzyme
Protease
Serine protease
Serine protease PA clan
Serine protease S29 family
|
- | - | - | - | 100 | |
Enzyme
Transferase
|
0 | - | - | - | - | |
Enzyme
|
0-0 | - | - | - | 100 | |
Ion channel
Voltage-gated ion channel
Potassium channels
Voltage-gated potassium channel
|
- | - | - | - | 1-2 | |
Unclassified protein
|
0-3 | - | - | - | - |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Hepatitis C, Chronic | 4 | D019698 | ClinicalTrials |
Hepatitis B, Chronic | 2 | D019694 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 1258226-87-7 |
ChEBI | 85183 |
ChEMBL | CHEMBL3127326 |
DrugBank | DB09296 |
DrugCentral | 4912 |
FDA SRS | 2302768XJ8 |
Guide to Pharmacology | 11272 |
PharmGKB | PA166163409 |
PubChem | 54767916 |
SureChEMBL | SCHEMBL8542284 |
ZINC | ZINC000150601177 |